These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10799808)

  • 1. Structure and serologic properties of O-specific polysaccharide from Citrobacter freundii possessing cross-reactivity with Escherichia coli O157:H7.
    Nishiuchi Y; Doe M; Hotta H; Kobayashi K
    FEMS Immunol Med Microbiol; 2000 Jun; 28(2):163-71. PubMed ID: 10799808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cross-reaction between the lipopolysaccharide O-polysaccharaide antigens of Escherichia coli O157:H7 and strains of Citrobcter freundii and Citrobacter sedlakii.
    Vinogradov E; Conlan JW; Perry MB
    FEMS Microbiol Lett; 2000 Sep; 190(1):157-61. PubMed ID: 10981707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and antigenic properties of Citrobacter freundii lipopolysaccharides.
    Chart H; Willshaw GA; Cheasty T; Rowe B
    J Appl Bacteriol; 1993 May; 74(5):583-7. PubMed ID: 7683640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults.
    Zapata-Quintanilla LB; Palmeira P; Tino-De-Franco M; Amaral JA; Carbonare CB; Carbonare SB
    Scand J Immunol; 2006 Dec; 64(6):661-7. PubMed ID: 17083623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn.
    Palmeira P; Yu Ito L; Arslanian C; Carneiro-Sampaio MM
    Eur J Pediatr; 2007 May; 166(5):413-9. PubMed ID: 17058099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological investigations on patients with hemolytic uremic syndromes due to enterohemorrhagic Escherichia coli O157:H7 infection].
    Xu J; Cheng B; Feng L; Jing H; Yang J; Zhao G; Wang H; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Apr; 23(2):114-8. PubMed ID: 12015093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody responses to R3-core epitopes on the lipopolysaccharide of Escherichia coli O157.
    Dalwai F; Chart H
    Lett Appl Microbiol; 2003; 37(6):429-32. PubMed ID: 14633093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of the Escherichia coli O157, O111, and O55 O-antigen gene clusters with those of Salmonella enterica and Citrobacter freundii, which express identical O antigens.
    Samuel G; Hogbin JP; Wang L; Reeves PR
    J Bacteriol; 2004 Oct; 186(19):6536-43. PubMed ID: 15375135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of enterohemorrhagic Escherichia coli serotype O157:H7 by flow cytometry using monoclonal antibodies.
    Kusunoki H; Kobayashi K; Kita T; Tajima T; Sugii S; Uemura T
    J Vet Med Sci; 1998 Dec; 60(12):1315-9. PubMed ID: 9879532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli.
    Chart H; Jenkins C
    J Appl Microbiol; 1999 May; 86(5):731-40. PubMed ID: 10347867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of O-serogroup serodiagnosis for patients with hemolytic uremic syndrome by Ec-LPS array].
    Amano K; Yatsuyanagi J; Saito S
    Kansenshogaku Zasshi; 2007 Jan; 81(1):26-32. PubMed ID: 17338313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli.
    Chart H; Cheasty T; Willshaw GA
    J Med Microbiol; 2002 Dec; 51(12):1050-1054. PubMed ID: 12466402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease.
    Currie CG; McCALLUM K; Poxton IR
    J Med Microbiol; 2001 Apr; 50(4):345-354. PubMed ID: 11289520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157.
    Westerman RB; He Y; Keen JE; Littledike ET; Kwang J
    J Clin Microbiol; 1997 Mar; 35(3):679-84. PubMed ID: 9041412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.
    Navarro A; Eslava C; Hernandez U; Navarro-Henze JL; Aviles M; Garcia-de la Torre G; Cravioto A
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):797-801. PubMed ID: 12965907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of latex agglutination tests for the detection of human antibodies to the lipopolysaccharides of verocytotoxin-producing Escherichia coli (VTEC) serogroups O157 and non-O157.
    Rastawicki W; Chróst A; Gielarowiec K
    J Microbiol Methods; 2017 Sep; 140():74-76. PubMed ID: 28732694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes.
    Asper DJ; Sekirov I; Finlay BB; Rogan D; Potter AA
    Vaccine; 2007 Nov; 25(49):8262-9. PubMed ID: 17980466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous and heterologous antibody responses to lipopolysaccharide after enterohemorrhagic Escherichia coli infection.
    Tsutsumi R; Ichinohe N; Shimooki O; Obata F; Takahashi K; Inada K; Sasaki M; Sato S; Chida S
    Microbiol Immunol; 2004; 48(1):27-38. PubMed ID: 14734855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.